ArticlePloS one2017

Addition of αGal HyperAcute™ technology to recombinant avian influenza vaccines induces strong low-dose antibody responses.

Wenlan Alex Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.